Gapping up
In reaction to earnings/guidance:
- ELAN +7.3%, ACRS +3.1%, GENI +3%, THS +1.9%, VTRS +1.8%, KKR +1.7%, BRK.B +1.6%, HSIC +1.2%, DK +1.1%
Other news:
- SQNS +32.4% (to be acquired by Renesas Electronics (RNECF) for $3.03 per ADS)
- TRHC +31.4% (to be acquired by Nautic Partners for $10.50 in cash per share and will combine with ExactCare Pharmacy)
- SOVO +25.1% (Campbell Soup to acquire SOVO for $23/share; expects deal to be accretive to adj. EPS by year two)
- NKLA +14.4% (amended and restated equity distribution agreement with Citigroup)
- DNA +5.9% (announces a new collaboration with Merck (MRK) focused on improving biologic manufacturing)
- AXSM +4.7% (receives notice from Hikma Pharma that Hikma has submitted an ANDA seeking approval for a generic version of Sunosi)
- BHG +3.4% (entered into a credit facility with an investment partnership of New Enterprise Associates with $60 million of credit capacity on August 4 2023) LBPH +3.1% (files $100 mln mixed shelf securities offering)
- AEVA +2.6% (announced that Railergy selected Aeva's Frequency Modulated Continuous Wave 4D LiDAR technology to power perception for its automatic train operation)
- ACHR +2.5% (positive Barron's article)
- COLL +2% (entered into an Accelerated Share Repurchase agreement with Jefferies to repurchase $50 mln of the Company's common stock)
- STBX +1.1% (Unveils a Groundbreaking Image-to-Image Processing Technology in AIGC Engine (StarboxGPT))
Analyst comments:
- CWH +3.5% (upgraded to Buy from Hold at Truist)
- W +2.8% (upgraded to Buy from Neutral at UBS)
- LAUR +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- PCG +1.3% (upgraded to Buy from Neutral at UBS)
- DVA +1.2% (upgraded to Buy from Neutral at UBS)
- UAL +1.2% (upgraded to Buy from Neutral at Redburn)